Synthesis and molecular docking study of some novel 2,3-disubstituted quinazolin-4(3H)-one derivatives as potent inhibitors of urease

被引:22
|
作者
Akyuz, Gulay [1 ]
Mentese, Emre [1 ]
Emirik, Mustafa [1 ]
Baltas, Nimet [1 ]
机构
[1] Recep Tayyip Erdogan Univ, Art & Sci Fac, Dept Chem, Rize, Turkey
关键词
Quinazolin-4(3H)-one; Urease inhibition; Furan; Oxadiazole; Molecular docking study; CRYSTAL-STRUCTURE; QUINAZOLINE; ALKALOIDS;
D O I
10.1016/j.bioorg.2018.06.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A new series of 2,3-disubstituted quinazolin-4(3H)-one compounds including oxadiazole and furan rings was synthesized. Their inhibitory activities on urease were assessed in vitro. All newly synthesized compounds exhibited potent urease inhibitory activity in the range of IC50 = 1.55 +/- 0.07-2.65 +/- 0.08 mu g/mL, when compared with the standard urease inhibitors such as thiourea (IC50 = 15.08 +/- 0.71 mu g/mL) and acetohydroxamic acid (IC50 = 21.05 +/- 0.96 mu g/mL). 2,3-Disubstituted quinazolin-4(3H)-one derivatives containing furan ring (3a-e) were found to be the most active inhibitors when compared with the compounds 2a-e bearing oxadiazole ring. Compound 3a, bearing 4-chloro group on phenyl ring, was found as the most effective inhibitor of urease with the IC50 value of 1.55 +/- 0.11 mu g/mL. The molecular docking studies of the newly synthesized compounds were performed to identify the probable binding modes in the active site of the Jack bean urease (JBU) enzymes.
引用
收藏
页码:121 / 128
页数:8
相关论文
共 50 条
  • [1] Synthesis of novel 2,3-disubstituted quinazolin-4(3H)-one derivatives containing hydrazone skeleton as potent urease inhibitors and their antimicrobial activities
    Akyuz, Gulay
    Beris, Fatih Saban
    Kahveci, Bahittin
    Mentese, Emre
    [J]. JOURNAL OF HETEROCYCLIC CHEMISTRY, 2019, 56 (11) : 3065 - 3072
  • [2] Synthesis, Antimicrobial Evaluation, Molecular Docking and Dynamics Simulations of Novel 2,3-Disubstituted Quinazolin-4(3H)-one Derivatives
    Verma, Priyanka
    Xiang, Lai Zhen
    Chaube, Udit
    Natesan, Gopal
    [J]. CHEMISTRYSELECT, 2024, 9 (36):
  • [3] Synthesis and spectral characterisation of novel 2,3-disubstituted quinazolin-4(3H)-one derivatives
    Soliman, El-Sayed A.
    [J]. JOURNAL OF CHEMICAL RESEARCH, 2012, (02) : 66 - 71
  • [4] Synthesis of some novel quinazolin-4(3H)-one hybrid molecules as potent urease inhibitors
    Mentese, Emre
    Akyuz, Gulay
    Yilmaz, Fatih
    Baltas, Nimet
    Emirik, Mustafa
    [J]. ARCHIV DER PHARMAZIE, 2018, 351 (12)
  • [5] Synthesis and Bioactivity Studies of 2,3-Disubstituted Quinazolin-4(3H)-one
    Ou, Junjun
    Liu, Kechang
    Wang, Yi
    Zhang, Hao
    Liu, Ruiquan
    Li, Qibo
    Wang, Qingmin
    Li, Yongqiang
    Rui, Changhui
    Liu, Shangzhong
    [J]. CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2014, 34 (03) : 526 - 536
  • [6] Synthesis and antimicrobial activity of some novel 2,3-disubstituted quinazolin-4(3H)ones
    Abbas, Safinaz E. S.
    Saafan, Amal E. M.
    [J]. BULLETIN OF PHARMACEUTICAL SCIENCES, 2007, 30 : 51 - 62
  • [7] Efficient one-pot tandem synthesis and cytotoxicity evaluation of 2,3-disubstituted quinazolin-4(3H)-one derivatives
    Hue Thi Buu Bui
    Kiep Minh Do
    Huy Tran Duc Nguyen
    Hieu Van Mai
    Thanh La Duc Danh
    De Quang Tran
    Morita, Hiroyuki
    [J]. TETRAHEDRON, 2021, 98
  • [8] Stereoselective synthesis of a 2,3-disubstituted 5-pyrrolidinone derivative of quinazolin-4(3H)-one
    Szabo, M
    Kokosi, J
    Kovacs, A
    Bocskei, Z
    Hermecz, I
    [J]. HETEROCYCLES, 1997, 45 (12) : 2437 - 2442
  • [9] Synthesis and pharmacological investigation of some novel 2,3-disubstituted quinazolin-4(3H)-ones as analgesic and antiinflammatory agents
    Alagarsamy, V
    Meena, S
    Vijayakumar, S
    Ramseshu, KV
    Revathi, R
    [J]. PHARMAZIE, 2003, 58 (04): : 233 - 236
  • [10] Synthesis, analgesic and anti-inflammatory activities of some novel 2,3-disubstituted quinazolin-4(3H)-ones
    Alagarsamy, V
    Muthukumar, V
    Pavalarani, N
    Vasanthanathan, P
    Revathi, R
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2003, 26 (04) : 557 - 559